APVO, DY: Overlooked Stocks
b'Aptevo Therapeutics (APVO) stock is up around 163% today with a $17.03 stock price. The clinical-stage, research, and development biotechnology company reported first complete remission. APVO is focused on developing immunotherapeutic candidates for treating different forms of cancer. Next, George Tsilis weighs in on the Dycom Industries (DY) stock, which is up around 20% today with a $99.91 stock price. DY is a provider of specialty contracting services.'